Model selection for analysis of dynamic contrast enhanced MRI (DCE-MRI) data.

被引:0
|
作者
Yankeelov T
Welch E B
Chakravarthy B
Lee R
Freehardt D
Mayer, I
Meszoely, I
Kelly M
Means-Powell J
Gore J
机构
[1] Vanderbilt Univ, Nashville, TN USA
[2] Philips Med Syst, Cleveland, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S45 / S45
页数:1
相关论文
共 50 条
  • [1] Unfolding of Aliased Dynamic Acquisitions for the Acceleration of Breast Dynamic-Contrast Enhanced MRI (DCE-MRI)
    Pineda, F.
    Medved, M.
    Fan, X.
    Karczmar, G.
    [J]. MEDICAL PHYSICS, 2016, 43 (06) : 3391 - 3391
  • [2] Incorporating contrast agent diffusion into the analysis of DCE-MRI data
    Pellerin, Martin
    Yankeelov, Thomas E.
    Lepage, Martin
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2007, 58 (06) : 1124 - 1134
  • [3] Is it possible to predict the radiosensitivity of cervical cancer using dynamic contrast enhanced MRI (DCE-MRI)?
    Szluha, Lazanyi K.
    Pintye, E.
    Benko, K.
    Der, A.
    Poka, R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 48 - 48
  • [4] Dynamic Contrast-Enhanced (DCE) MRI
    Li, Xin
    Huang, Wei
    Holmes, James H.
    [J]. MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2024, 32 (01) : 47 - 61
  • [5] Variability analysis of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) of hepatocellular carcinoma (HCC)
    Reddy, Kaunteya
    Tennant, Bud
    Buitrago, Sandra
    Hutson, Alan
    Ashton, Edward
    Iyer, Renuka
    [J]. CANCER RESEARCH, 2012, 72
  • [6] An Adaptive Model for Pharmacokinetic Nested Model Selection in Dynamic Contrast Enhanced MRI Data Analysis
    Bagher-Ebadian, H.
    Behbahani, M. Mohammadian
    Ewing, J.
    [J]. MEDICAL PHYSICS, 2016, 43 (06) : 3831 - 3831
  • [7] Biomarker comparison and selection for prostate cancer detection in Dynamic Contrast Enhanced-Magnetic Resonance Imaging (DCE-MRI)
    Aguado-Sarrio, E.
    Prats-Montalban, J. M.
    Sanz-Requena, R.
    Garcia-Marti, G.
    Marti-Bonmati, L.
    Ferrer, A.
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2017, 165 : 38 - 45
  • [8] Dynamic contrast enhanced-MRI (DCE-MRI) as a pharmacodynamic biomarker for pazopanib (PZ) in metastatic renal carcinoma (RC).
    Sweis, Randy F.
    Medved, Milica
    Towey, Shannon
    Karczmar, Greg S.
    Oto, Aytekin
    Szmulewitz, Russell Zelig
    O'Donnell, Peter H.
    Fishkin, Paul A. S.
    Stadler, Walter Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Dynamic contrast enhanced MRI (DCE-MRI) as a potential predictor of clinical response in patients with inflammatory breast cancer (IBC).
    Doshi, A
    Wedam, SB
    Thomasson, DM
    Garcia-Eulate, RM
    Wise, BJ
    Yao, J
    Steinberg, SM
    Liewehr, DJ
    Choyke, P
    Swain, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 24S - 24S
  • [10] DCE-MRI Data Analysis for Cancer Area Classification
    Castellani, U.
    Cristani, M.
    Daducci, A.
    Farace, P.
    Marzola, P.
    Murino, V.
    Sbarbati, A.
    [J]. METHODS OF INFORMATION IN MEDICINE, 2009, 48 (03) : 248 - 253